APA (7th ed.) Citation

Sato, G., Uchino, H., Takuma, K., Saito, M., Fuchigami, A., Iwata, Y., . . . Hirose, T. (2026). Real-World Effectiveness and Safety of Escalating Once-Weekly Semaglutide from 0.5 to 1.0 mg in Type 2 Diabetes. Diabetes Therapy, 17(5), 753. https://doi.org/10.1007/s13300-026-01864-6

Chicago Style (17th ed.) Citation

Sato, Genki, Hiroshi Uchino, Kota Takuma, Manabu Saito, Ayako Fuchigami, Yoko Iwata, Fukumi Yoshikawa, and Takahisa Hirose. "Real-World Effectiveness and Safety of Escalating Once-Weekly Semaglutide from 0.5 to 1.0 mg in Type 2 Diabetes." Diabetes Therapy 17, no. 5 (2026): 753. https://doi.org/10.1007/s13300-026-01864-6.

MLA (9th ed.) Citation

Sato, Genki, et al. "Real-World Effectiveness and Safety of Escalating Once-Weekly Semaglutide from 0.5 to 1.0 mg in Type 2 Diabetes." Diabetes Therapy, vol. 17, no. 5, 2026, p. 753, https://doi.org/10.1007/s13300-026-01864-6.